Since the founding of Key Lab in 1998, we have maintained
an integrated approach to vision research, education and patient
care. Led by Dr. Lixin Xie, the only academician of ophthalmology
in China, we have dedicated ourselves to translating our fundamental
discoveries into technologies, treatments and policies so
as to better serve our patients as well as to improve the
world in which we live. This goal is achieved through joint
efforts between our basic scientists and clinicians from a
broad range of disciplines, in addition to crucial contributions
from colleagues of the whole institute.
As a national-renowned lab equipped with state-of-the-art
facilities, we direct our main efforts to molecular biology
and immunology, and also conduct research in such areas as
tissue engineering in ophthalmology, the pathogenesis and
latest treatments for various ocular diseases.
Our key lab embraces a vibrant and rapidly growing
research team and is known for the strength of its research
programs. Spanning both the basic
sciences and clinical
care , we boast a good record of undertaking successively
29 research projects which includes one national 863 Research
Program, 5 National Natural Science Foundation projects, 4
research patents and ect.
In terms of international collaboration, we
have been keeping close academic contact with first-class
oversea institutes including U. S. Louisiana State University
Eye Center, exchanging fellows regularly and organizing international
symposiums on ophthalmology annually. Moreover, we invited
13 world-renowned experts as visiting professors, such as
Prof. Herbert E. Kaufman and Prof. Byran M. Gebhardt from
U. S. Louisiana State University, Prof. Scheffer C.G. Tseng
from Bascom Palmer Eye Institute, School of Medicine, University
of Miami, and Prof. Youhai Chen from University of Pennsylvania,
to name just a few. 
Today, we are building on that strong tradition and launching
new programs for the future. We will continue our daily drive
to find the causes of vision disorders, to discover the cures,
to achieve academic and scientific excellence, and above all,
to better serve the vision needs of mankind.
|
